The Dual Pi3/Pim-Kinase Inhibitor, Ibl-202, Is Highly Synergistic With Venetoclax Against Cll Cells, And Tp53-Knock-Out Cells, And Under Conditions That Mimic The Tumor Microenvironment

BLOOD(2018)

引用 2|浏览1
暂无评分
摘要
Background
更多
查看译文
关键词
cll cells,venetoclax,inhibitor,dual pi3/pim-kinase,knock-out
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要